Home
Foresite Capital Fund IV reported a 7.6% stake in Lyell Immunopharma LYEL · 1,454,616 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.6%
- Last report
- 9.2% · filed 25/05/15
- Shares held
- 1,454,616 sh
- Class
- Common Stock, par value $0.0001
- Holder
- Foresite Capital Fund IV
- Event date
- 25/09/30
- Filed
- 25/11/14
7.6% stake · −1.6pp from the last report
- Stake
- 7.6%
- Last report
- 9.2%
- Since last report
- −1.6pp
Lyell Immunopharma trades, last 26 weeks
What else happened in Lyell Immunopharma around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Foresite Capital Fund IV's other 5% stake reports
- Foresite Capital Fund IV
5% stakeLyell Immunopharma
5% stakeLyell Immunopharma
LYEL
2.7% stake
653,328 sh
2.7% stake
Filed 08/14
- Foresite Capital Fund IV
5% stakeEikon Therapeutics
5% stakeEikon Therapeutics
EIKN
7.7% stake
4,148,519 sh
7.7% stake
Filed 02/11
- Foresite Capital Fund IV
5% stakeMaze Therapeutics
5% stakeMaze Therapeutics
MAZE
1.4% stake
608,948 sh
1.4% stake
Filed 25/11/14
- Foresite Capital Fund IV
5% stakeLyell Immunopharma
5% stakeLyell Immunopharma
LYEL
9.2% stake
27,161,892 sh
9.2% stake
Filed 25/05/15
- Foresite Capital Fund IV
5% stakeMaze Therapeutics
5% stakeMaze Therapeutics
MAZE
5.6% stake
2,457,108 sh
5.6% stake
Filed 25/02/07
